FdaApplication
NDA 020539
Identifiers
- fda_app_no: NDA020539
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 1996-05-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMISIL | TERBINAFINE HYDROCHLORIDE | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
1 product